Afya (NASDAQ:AFYA) Downgraded by Bank of America to “Neutral”

Bank of America lowered shares of Afya (NASDAQ:AFYA) from a buy rating to a neutral rating in a report issued on Tuesday morning, MarketBeat Ratings reports. Bank of America currently has $17.00 target price on the stock, down from their previous target price of $22.00.

Several other research analysts have also recently weighed in on AFYA. Weiss Ratings reissued a “hold (c)” rating on shares of Afya in a research report on Wednesday, January 21st. Sanford C. Bernstein upgraded shares of Afya to a “market perform” rating in a report on Friday, January 16th. JPMorgan Chase & Co. reissued a “neutral” rating and issued a $22.00 price target (down from $24.50) on shares of Afya in a research note on Wednesday, January 7th. UBS Group restated a “neutral” rating and set a $16.00 price target (down from $18.00) on shares of Afya in a report on Friday, January 16th. Finally, Wall Street Zen cut Afya from a “strong-buy” rating to a “buy” rating in a report on Saturday, January 31st. One equities research analyst has rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $17.30.

Afya Stock Performance

NASDAQ AFYA opened at $13.86 on Tuesday. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.98 and a current ratio of 0.98. The stock’s fifty day moving average is $14.71 and its two-hundred day moving average is $14.89. The firm has a market capitalization of $1.30 billion, a P/E ratio of 9.97, a price-to-earnings-growth ratio of 0.52 and a beta of 0.50. Afya has a fifty-two week low of $13.12 and a fifty-two week high of $19.90.

Institutional Investors Weigh In On Afya

A number of institutional investors have recently modified their holdings of AFYA. Doma Perpetual Capital Management LLC raised its holdings in shares of Afya by 50.6% in the 3rd quarter. Doma Perpetual Capital Management LLC now owns 891,639 shares of the company’s stock valued at $13,910,000 after buying an additional 299,419 shares during the period. Swedbank AB grew its position in Afya by 170.3% in the 4th quarter. Swedbank AB now owns 189,200 shares of the company’s stock valued at $2,916,000 after acquiring an additional 119,200 shares in the last quarter. SPX Gestao de Recursos Ltda purchased a new stake in Afya during the third quarter worth about $2,895,000. State Street Corp lifted its position in shares of Afya by 25.8% during the fourth quarter. State Street Corp now owns 126,914 shares of the company’s stock worth $1,955,000 after purchasing an additional 26,005 shares in the last quarter. Finally, GSA Capital Partners LLP lifted its position in shares of Afya by 45.5% during the third quarter. GSA Capital Partners LLP now owns 89,747 shares of the company’s stock worth $1,400,000 after purchasing an additional 28,053 shares in the last quarter. 88.02% of the stock is owned by institutional investors and hedge funds.

About Afya

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.